Usage Information
Citation Information: J Clin Invest. 1982;69(3):684-690. https://doi.org/10.1172/JCI110496.
Abstract
Using the isolated perfused canine tibia we examined the extraction of [3H]25(OH)D3, [3H]1,25(OH)2D3 and [3H]24,25(OH)2D3 by bone of normal adult dogs. The studies were performed with and without vitamin D binding protein (DBP) in the perfusate to examine the effect of protein binding on the extraction of the vitamin D metabolites. An average of 48±2% of [3H]25(OH)D3 was extracted by bone, when no DBP was present. However, addition of only a small amount of DBP (∼720 ng/ml of perfusate) nearly completely abolished the extraction of [3H]25(OH)D3 by bone. No degradation and/or transformation of the labeled 25(OH)D3 could be demonstrated during passage through the isolated perfused bone. The extraction of [3H]24,25(OH)2D3 in a DBP-free medium averaged 33±5%. Addition of 720 ng of DBP/ml of perfusate completely inhibited the extraction of this metabolite. The extraction of [3H]1,25(OH)2D3 averaged 30±3% in a DBP free medium and no inhibition of the extraction was demonstrated after addition of DBP (720 ng/ml of perfusate). However, addition of DBP in a concentration of 14.4 μg/ml of perfusate reduced the extraction of 1,25(OH)2D3 to 8±2%, a value still significantly higher than that seen after addition of 20 times less DBP to perfusions with 25(OH)D3 and 24,25(OH)2D3. It is concluded that the isolated perfused bone of normal dogs can extract significant amounts of 25(OH)D3, 1,25(OH)2D3, and 24,25(OH)2D3. Small concentrations of DBP (720 ng/ml) in the perfusate significantly inhibited the extraction of 25(OH)D3 and 24,25(OH)2D3. A carrier role for DBP is suggested and it is proposed that the levels of free vitamin D are important for extraction of the metabolites by bone. Therefore, due to the different affinities of DBP for the various metabolites of vitamin D, only 1,25(OH)2D3 is extracted in vitro in significant amounts by bone of normal adult dogs, in the presence of DBP.
Authors
K. Olgaard, J. Schwartz, D. Finco, M. Arbelaez, J. Haddad, L. Avioli, S. Klahr, E. Slatopolsky
Usage data is cumulative from November 2023 through November 2024.
| Usage | JCI | PMC |
|---|---|---|
| Text version | 133 | 0 |
| 77 | 13 | |
| Scanned page | 231 | 4 |
| Citation downloads | 43 | 0 |
| Totals | 484 | 17 |
| Total Views | 501 | |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.
Copyright © 2024 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)